BE689377A - - Google Patents

Info

Publication number
BE689377A
BE689377A BE689377DA BE689377A BE 689377 A BE689377 A BE 689377A BE 689377D A BE689377D A BE 689377DA BE 689377 A BE689377 A BE 689377A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE689377A publication Critical patent/BE689377A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE689377D 1965-11-10 1966-11-07 BE689377A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF0047633 1965-11-10

Publications (1)

Publication Number Publication Date
BE689377A true BE689377A (xx) 1967-05-08

Family

ID=7101748

Family Applications (1)

Application Number Title Priority Date Filing Date
BE689377D BE689377A (xx) 1965-11-10 1966-11-07

Country Status (6)

Country Link
US (1) US3470297A (xx)
BE (1) BE689377A (xx)
DE (1) DE1545873A1 (xx)
FR (1) FR5959M (xx)
GB (1) GB1129158A (xx)
NL (1) NL6615899A (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932645A (en) * 1971-04-10 1976-01-13 Farbenfabriken Bayer Ag Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid
US3932646A (en) * 1971-04-10 1976-01-13 Farbenfabriken Bayer Ag Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylate
DE2218644C3 (de) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4020178A (en) * 1973-07-12 1977-04-26 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters used as coronary dilators and anti-hypertensives
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines

Also Published As

Publication number Publication date
GB1129158A (en) 1968-10-02
DE1545873A1 (de) 1970-02-26
US3470297A (en) 1969-09-30
FR5959M (xx) 1968-04-16
NL6615899A (xx) 1967-05-11

Similar Documents

Publication Publication Date Title
BE674763A (xx)
FR5959M (xx)
JPS4947168B1 (xx)
JPS4116088Y1 (xx)
JPS4116633Y1 (xx)
JPS4120370Y1 (xx)
JPS4215475Y1 (xx)
JPS4313219Y1 (xx)
JPS4318338Y1 (xx)
JPS4529757Y1 (xx)
BE674906A (xx)
BE672829A (xx)
BE675251A (xx)
BE672563A (xx)
BE667239A (xx)
BE672548A (xx)
BE672509A (xx)
BE668330A (xx)
SE303330B (xx)
NL7004707A (xx)
NL6517023A (xx)
NL6515493A (xx)
LU50573A1 (xx)
BE672703A (xx)
BE674764A (xx)